FreeTender
Accepting bidsitbPoland

Poland – Pharmaceutical products – Dostawa leku do badania klinicznego (Tirzepatyd)

Poland – Pharmaceutical products – Delivery of the medicine for clinical trial (Tireptide)English, machine translated

Issued by Uniwersytecki Szpital Kliniczny nr 4 w Lublinie · via TED — Tenders Electronic Daily (EU)

Verify & apply on the official portal →
Published
5 Nov 2026
Closes
16 Nov 2026, 23:59 UTC
Reference
769378-2026
Location
Poland
Sector
Healthcare & Pharma
Type
goods

At a glance

Uniwersytecki Szpital Kliniczny nr 4 w Lublinie in Poland has published an invitation to bid in healthcare & pharma: “Poland – Pharmaceutical products – Dostawa leku do badania klinicznego (Tirzepatyd)”. Submissions close on 16 November 2026, 12 days from today. Quote reference 769378-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 28 notices from this buyer since 2026, 9 of them currently open. There are 1,095 open healthcare & pharma notices in Poland on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

English summary

Machine translated from Polish by FreeTender. The original notice below is the binding text.

The subject of the procedure is the delivery of a medicine for clinical trial (Tirepatid). The contract is carried out as part of a project financed by the state budget from the Agency for Medical Research, Project No. 2025/ABM/01/00044 "Non-commercial, randomised, controlled clinical trial III Head-to-head phase, assessing the effectiveness and safety of the use of Tirepatid and/or intensive insulin therapy in the model continuous subcutaneous insulin infusion using an automatic, advanced hybrid closed-loop system in patients with chronically uncompensated type diabetes mellitus ...

Details

Przedmiotem postępowania jest dostawa leku do badania klinicznego (Tirzepatyd). Zamówienie realizowane jest w ramach projektu finansowanego ze środków budżetu państwa od Agencji Badań Medycznych, numer Projektu 2025/ABM/01/00044 „Niekomercyjne, randomizowane, kontrolowane badanie kliniczne III Fazy typu head to head, oceniające efektywność i bezpieczeństwo zastosowania tirzepatydu i/lub intensywnej insulinoterapii w modelu ciągłego podskórnego wlewu insuliny z wykorzystaniem automatycznego, zaawansowanego hybrydowego systemu zamkniętej pętli u pacjentów z przewlekle niewyrównaną cukrzycą typu 1 i współistniejącą nadwagą (OW) lub chorobą otyłościową oraz towarzyszącymi zaburzeniami neuropsychiatrycznymi.”

Lots Lot 1 — Lek do badania klinicznego (Tirzepatyd): Przedmiotem postępowania jest dostawa leku do badania klinicznego (Tirzepatyd).

Buyer: Uniwersytecki Szpital Kliniczny nr 4 w Lublinie

Buyer country: POL

Procedure: open

CPV code: 33600000

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 28 notices from Uniwersytecki Szpital Kliniczny nr 4 w Lublinie, going back to September 2026 — 9 of them still open. They buy mostly in Healthcare & Pharma, Agriculture & Food and Manufacturing & Supply. There are 1,095 open Healthcare & Pharma tenders in Poland. This one closes in 12 days.

More from this buyer

Similar Healthcare & Pharma tenders

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →